Table I. Clinical and Molecular Findings of the Seven Evaluated Patients.
Family 1 | Family 2 | Family 3 | Family 4 | Family 5 | Family 6 | ||
---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | |
Phenotype | MMIHS | MMIHS | MMIHS | MMIHS | MMIHS | CIPO | MSMDS |
Parental | + | + | − | − | − | − | − |
consanguinity | |||||||
Familial | + (Patient 2) | + (Patient 1) | − | − | − | − | − |
recurrence | |||||||
Pathogenic | |||||||
variant | |||||||
ACTG2* | NE | Not identified | C.532c>T (p.Argl78Cys) Het—de novo | c770G>A (p.Arg257His) Het—de novo | .533G>T (p.Arg178Leu) Het—de novo | c.584C>T (p.Thr195lle) Het— unknown origin | Not identified |
ACTA2* | NE | Not identified | NE | NE | NE | NE | c. 535c>T (p.Arg179Cys) Het—unknown origin |
MYH11** | NE | Not identified | NE | NE | NE | NE | NE |
Gender | M | F | M | F | M | F | F |
Newborn data | Live | Live | Live | Live | Live | Live | Live |
vitality | |||||||
Weight [g] (centile) | 1,935 (<p10) | 4,150 (>90) | 2,600 (10–25) | 3,360 (50–75) | 3,025 (75–90) | 3,320 (50–75) | 3,690 (75–90) |
Length [cm] (centile) | 38 (<p10) | 50 (50–75) | 42 (10) | 50 (25–50) | 49 (75–90) | NS | 48 (10–25) |
OFC [cm] (centile] | 31 (p10) | 34.5 (50–75) | 32 (25) | 36 (90) | 33 (50–75) | NS | 35 (75) |
Gestational age [weeks] | 36 | 38 | 36 | 39 | 35 | 37 | 38 |
Apgar score | 3/8 | 9/10 | 7/10 | 9/10 | 8/9 | NE | 8/9/9 |
Age | Death (1 mo) | Death (1 y 8 mo) | Death (7 mo) | Death (11 mo) | 5 mo | 5y | 2 y 10 mo |
Paternal age (years)a | 21 | 23 | 30 | 38 | 32 | 34 | 38 |
Maternal age (years)a | 24 | 2B | 29 | 34 | 25 | 27 | 29 |
Prenatal findings | Hydronephrosis, megacystis, oligohydramnios | Hydronephrosis, megacystis, polyhydramnios | Hyperechogenic kidneys, hydroureter, megacystis, club feet | Megacystis, polyhydramnios | Megacystis | Megacystis | Hydronephrosis, hydroureter, megacystis |
Fetal bladder diversion | Vesicoamniotic shunt | − | − | − | − | − | − |
Megacystis | + | + | + | + | + | Episodic | + |
Prune-belly | + | + | + | − | − | − | − |
phenotype | |||||||
Microcolon | + | + | + | − | + | − | − |
Intestinal hypoperistalsis | + | + | + | + | + | + | + |
Mydriasis | NE | + | − | − | − | − | + |
Parenteral lnutrition dependence | + (Total) | + (Total) | + (Total) | + (Total after 4 mo) | + (Total) | + (Intermittent) | + (Intermittent) |
Bladder catheterization and/or vesicostomy | + | + | + | + | + | − | + |
Other findings | Hydronephrosis, sparse renal cyst, renal failure, dilated stomach, intestinal malrotation, hypoplastic terminal ileum | Hydronephrosis, intestinal malrotation, hypoplastic small intestine | Hydronephrosis, renal cysts, hydroureter, stomach dilatation | Cerebral ventriculomegaly, temporal epileptiform discharges | Stomach and large intestine dilatation | Hydronephrosis, hydroureter, intestinal malrotation, ASD, ductus arteriosus aneurysm, pulmonary valve dilatation, cerebrovascular abnormalities | |
Histologic findings | Renal dysplasia, chronic pyelonephritis, acute tubular necrosis, intrahepatic cholestasis | Vacuolization of muscularis propria layer (bladder and small intestine) | NE | Normal (stomach, small and large intestine) | Enterocolitis | Vacuolization and fibrosis of muscularis propria layer (stomach, gallbladder, small and large intestine) | Normal (large intestine) |
Surgery | Exploratory laparotomy, gastrostomy, ileostomy, vesicostomy, appendicectomy | Gastrostomy, ileostomy, vesicostomy, multivisceral transplantation | Ileostomy, vesicostomy | Gastrostomy, ileostomy | Ileostomy | Ileostomy, partial gastrectomy with Roux loop anatomosis, cholecystectomy, exploratory laparotomy, right hemicolectomy | Ligation of ductus arteriosus, gastrostomy, sigmoid resection |
Follow up | Deceased | Deceased | Deceased | Deceased | Supportive treatment | Episodic intestinal pseudo-obstruction, supportive treatment | Supportive treatment |
parental age in years at the birth of the patient; ASD, atrial septal defect; CIPO, chronic intestinal pseudo-obstruction; F, female; Het, heterozygous; M, male; MMIHS, megacystis-microcolon-intestinal hypoperistalsis; mo, months old; MSMDS, i smooth muscle dysfunction syndrome; NE, not evaluated; OFC, occipital frontal circumference; y, years old; +, feature present; —, feature absent.
Evaluated by Sanger sequencing in patients 2-7 (both genes were also tested by whole-exome sequencing in patient 2).
Evaluated by whole-exome sequencing in patient 2.